Cergentis

Utrecht, Netherlands Founded: 2012 • Age: 14 yrs Acquired By Solvias
Kits and services for targeted gene sequencing are provided.

About Cergentis

Cergentis is a Healthcare company based in Utrecht (Netherlands) founded in 2012, and was acquired by Solvias in July 2022. Kits and services for targeted gene sequencing are provided. Its Indian entity Ironsource India Private Limited reported revenue of β‚Ή21.75 Cr. Cergentis offers products and services including Targeted Locus Amplification (TLA). Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents.

Company details

Cergentis was founded in 2012 and is based in Utrecht, Netherlands. Targeted sequencing kits and services are offered in the genomics sector. The proprietary Targeted Locus Amplification (TLA) technology is employed to achieve complete next-generation sequencing of genomic loci through a single primer pair, amplifying thousands of base pairs. Applications encompass oncogenetics, transgene integration site analysis, full gene sequencing, genetic diagnostics, and agricultural genomics.

Key Metrics
  • Indian entity revenue
    ₹21.75 Cr

    FY 2025 · +206% YoY

  • Indian entity net profit
    ₹3.79 Cr

    FY 2025 · 17% margin

  • Indian entity EBITDA
    ₹5.88 Cr

    FY 2025 · 27% margin

  • Latest Funding Round
    $1.41M (USD), Grant

    Apr 2020

  • Investors
    Solvias

    & 2 more

  • Acquired by
    Solvias

    (Jul 2022)

Products & Services of Cergentis

Cergentis offers a comprehensive portfolio of products and services, including Targeted Locus Amplification (TLA).

Targeted Locus Amplification (TLA)
Genetic Technology

Platform for genetic characterization and QC in advanced therapies.

Apps and channels of Cergentis

its YouTube channel Solvias AG has 23 subscribers and 30 videos.

Solvias AG
YouTube 23 subscribers 30 videos Science & Technology
Open channel

Videos from Cergentis

The most watched videos on Cergentis's YouTube channel, Solvias AG (23 subscribers). Click a video to play it here.

Webinar: Accurate Vector Copy Number VCN determination in Gene Modified Cellular Products
309 views
Navigating Complexity: Tailoring Cell Based Bioassays for Advanced Therapeutics
142 views
Strategies for Determining Critical Quality Attributes of Nucleic Acid Therapeutics & Their Carriers
123 views
Webinar: Biopharmaceuticals, Cell & Gene Therapy. Single-Use Technology and Extractable/Leachables:
123 views

More on Solvias AG.

Funding Insights of Cergentis

  • Total Rounds 2
  • Last Round Grant β€” $1.41M
  • First Round $1.55M

    (May 2018)

  • Investors Count 2

All 2 funding rounds of Cergentis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2020$1.41MGrant––
May 2018$1.55MGrant––
Valuation history

3 investors in total: 3 institutional.

Investors in Cergentis

Cergentis has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Solvias, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Integrated R&D services are provided for pharmaceuticals and allied sectors.
1999solvias.comKaiseraugst, Switzerland
Premium access

Investor details for Cergentis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Ironsource India Private Limited (Cergentis)

Ironsource India Private Limited is the primary company behind Cergentis. The board of Ironsource India Private Limited currently have 4 directors; the longest-serving is Nora Sen Go, appointed in 2024. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Nora Sen Go
DIN 10531941
Director04 Mar 20242 yrs 8 moIronsource India Private Limited
Bhagavant Bedi
DIN 08005696
Director21 Nov 20241 yr 11 moIronsource India Private Limited
Jasmine De Layton
DIN 10792925
Director08 Jul 20251 yr 4 moIronsource India Private Limited
Shridhar Subbaraman Iyer
DIN 07151577
Director30 Oct 20251 yrIronsource India Private Limited

People of Cergentis

22 people are tracked at Cergentis (1 in leadership, 8 in board & advisors, 13 in team).

NameRoleGroup
Erik Splinter
General ManagerLeadership
Dirk Pollet
Supervisory Board MemberBoard & advisors
Jan Groen
ChairmanBoard & advisors
Wim Van Criekinge
Board MemberBoard & advisors
Frank Grosveld
Scientific AdvisorBoard & advisors
Sabine Linn
Scientific AdvisorBoard & advisors
Han Brunner
Scientific AdvisorBoard & advisors
Wouter De Laat
Scientific AdvisorBoard & advisors
Maja Sanders
Supervisory Board MemberBoard & advisors
Maya Wright Clark
Sales And Account ManagerTeam
Frans - Paul Ruzius
Bioinformatician & Full-Stack DeveloperTeam
Juan Jose Fernandez Palacio
Business DeveloperTeam
Cheryl Dambrot
Scientific Account ManagerTeam
Clara Esteban
Project ScientistTeam
Maurijn Kessels
Service Team TechnicianTeam
Sanne Vonk
Quality Assurance ManagerTeam
Marcel Gross
Project Leader LIMSTeam
Mario Cangiano
Bioinformatics ScientistTeam
Vera Boersma
Bioinformatics And Software Development Team LeadTeam
Irene Santos Barriopedro
Product DeveloperTeam

2 more people are available in the full profile.

Premium access

Complete people profiles for Cergentis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Cergentis

Figures of Ironsource India Private Limited, the primary company behind Cergentis, for FY 2025. Revenue was ₹21.75 Cr (+206% year on year). Net profit was ₹3.79 Cr (17% margin). EBITDA was ₹5.88 Cr (27% margin). Revenue has grown at a compounded annual rate of +87% over three years and +59% over five years.

  • ₹21.75 CrRevenue · FY 2025 · +206% YoY
  • ₹3.79 CrNet profit · 17% margin
  • ₹5.88 CrEBITDA · 27% margin
  • ₹1 LakhPaid-up capital
  • 21Employees (provident fund records)
  • +87%Revenue CAGR, 3 years
  • +59%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ironsource India Private Limited are on its company page.

Premium access

Detailed financial statements for Cergentis

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Cergentis

4 dated milestones of Cergentis across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cergentis is founded.
  2. Funding First funding round of $1.6M.
  3. Funding Latest funding round, Grant, of $1.4M.
  4. Exit Acquired by Solvias.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cergentis

Premium access

Complete news archive for Cergentis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cergentis

Cergentis was founded in 2012 and raised its 1st funding round 6 years after it was founded.

Cergentis is headquartered in Utrecht, Netherlands.

The primary company behind Cergentis, Ironsource India Private Limited, reported revenue of β‚Ή21.75 Cr for FY 2025, up 206% year on year.

Cergentis was founded in 2012 and is based in Utrecht, Netherlands. Targeted sequencing kits and services are offered in the genomics sector. The proprietary Targeted Locus Amplification (TLA) technology is employed to achieve complete next-generation sequencing of genomic loci through a single primer pair, amplifying thousands of base pairs. Applications encompass oncogenetics, transgene integration site analysis, full gene sequencing, genetic diagnostics, and agricultural genomics.

Cergentis offers Targeted Locus Amplification (TLA).

Cergentis has 3 investors. Key investors include Solvias, European Union, and EIC Fund.

Cergentis operates through Ironsource India Private Limited.

Yes. Cergentis was acquired by Solvias in July 2022.

The legal entities of Cergentis currently have 4 directors, including Nora Sen Go, Bhagavant Bedi, Shridhar Subbaraman Iyer and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available